Abstract
We identified a group of 24 young (less than 50 years of age) women with isolated, premature atherosclerotic aortoiliac occlusive disease and attempted to identify distinguishing hemostatic characteristics. Most of these patients (62%) presented with acute thromboembolic events (blue toe syndrome, n=6; macroemboli, n=6; or aortoiliac thrombosis, n=3). Aortoiliac reconstruction (aortoiliac endarterectomy, n=10; aortobifurcation bypass grafts, n=6; and percutaneous angioplasty, n=4) was complicated by early thrombosis in 6 of 20 cases (30%), (1 of 10 endarterectomies, 4 of 6 bypass grafts, and 1 of 4 angioplasties). Fresh thrombus overlying an atherosclerotic plaque was a common finding at surgery. This observation and the relatively high incidence of thromboembolic events led us to hypothesize that a characteristic hemostatic profile might underlie the remarkably similar clinical presentations of these women. Levels of antiphospholipid antibodies (anticardiolipin antibodies and lupus anticoagulant), plasminogen activator inhibitor-1, fibrinogen, antithrombin III, protein C, protein S, plasminogen, prothrombin fragment F1+2, and D-dimer were determined for these young women and for 21 age-matched white female control subjects without vascular disease and nine white male patients with aortoiliac occlusive disease (mean 61 years, range 43 to 74 years). The incidence of anticardiolipin antibodies was 42% (8 of 19) in the female patients, which was significantly elevated (p=0.028). The female (62.5%) and male (100%) patients had significantly elevated D-dimer levels (p<0.001). Deficiencies of antithrombin III, protein C, and protein S were rare. A unique pattern of premature aortoiliac atherosclerosis exists in some young women. Intra-arterial thromboembolic events are common at presentation and complicate surgical management. The role of antiphospholipid antibodies remains uncertain.
Similar content being viewed by others
References
Boyd AM. The natural course of arteriosclerosis of the lower extremities. Angiology 1960;11:10–14.
DeBakey M, Crawford E, Garrett H, et al. Occlusive disease of the lower extremities in patients 16 to 37 years of age. Ann Surg 1964;159:873–890.
Duncan W, Linton R, Darling R. Aortoiliofemoral atherosclerotic occlusive disease: Comparative results of endarterectomy and Dacron bypass grafts. Surgery 1971;70:974–984.
Cronenwett JL, Davis J Jr, Gooch JB, et al. Aortoiliac occlusive disease in women. Surgery 1980;88:775–783.
Valentine R. Premature peripheral atherosclerosis. Cardiovasc Surg 1993;1:473–480.
Van Vroonhoven T. Intermittent claudication in premenopausal women — A correlation with the long-term use of oral contraceptives? J Cardiovasc Surg 1977;18:291–295.
Staple T. The solitary aortoiliac lesion. Surgery 1968;64:569–576.
Greenhalgh RM, Taylor GW. Little women with blocked aortas. Br J Surg 1974;61:923–924.
DeLaurentis D, Friedmann P, Wolferth C Jr, et al. Atherosclerosis and the hypoplastic aortoiliac system. Surgery 1978;83:27–37.
Costantino MJ, Smith RB III, Perdue GD. Segmental aortic occlusion: An unusual lesion in menopausal women. Arch Surg 1979;114:317–318.
Holmes DR Jr, Burbank M, Fulton R, et al. Arteriosclerosis obliterans in young women. Am J Med 1979;66:997–1000.
Weiss N. Premature menopause and aortoiliac occlusive disease. J Chron Dis 1972;25:133–138.
Perler BA, Kadir S, Williams GM. Aortic mural thrombus in young women: Premature arteriosclerosis or separate clinical entity? Surgery 1991;110:912–916.
Martinoli JL, Stocker K. Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 1986;43:253–264.
Wolf M, Boyer-Neumann C, Martinoli JL, et al. A new functional assay for human protein S activity using activated factor V as substrate. Thromb Haemost 1989;62:1144–1145.
Ubbink JB, Hayward Vermaak WJ, Bissport S. Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441–446.
Bick R, Baker W. Antiphospholipid and thrombosis syndromes. Semin Thromb Hemost 1994;20:3–15.
Darling RC, Brewster DC, Hallett JW Jr, et al. Aorto-iliac reconstruction. Surg Clin North Am 1979;59:565–579.
Broome A, Christenson JT, Eklof B, et al. Aorto-iliac disease in premenopausal women. Acta Chir Scand 1980;146:555–557.
Najafi H, Ostermiller WE, Ardekani RG, et al. Aortoiliac reconstruction in patients 32 to 45 years of age. Arch Surg 1970;101:780–783.
Naylor AR, Ah-See AK, Engeset J. Aortoiliac endarterectomy: An 11-year review. Br J Surg 1990;77:190–193.
Pokrovsky AV. Nonspecific aortoarteritis. In Rutherford RB, ed. Vascular Surgery, 3rd ed, vol 1. Philadelphia: WB Saunders, 1989, pp 217–237.
Ueda H. Clinical and pathologic studies of aortitis syndrome. Jpn Heart J 1968;9:76.
Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105–1110.
Hall R, Bunch GA. Aortoiliac occlusion in women using oral contraceptives. Br J Surg 1971;58:508–509.
Sachs S, Green R, DeWeese J. Segmental thrombotic occlusion of infrarenal abdominal aorta. Arch Surg 1982;117:1339–1342.
O'Connor J, Pollock JG. Acute arterial occlusion and the contraceptive pill. J Cardiovasc Surg 1975;16:1176–1180.
Jespersen J. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Dan Med Bull 1988;35,1:sec.6.5.3.
Keown D. Review of arterial thrombosis in association with oral contraceptives. Br J Surg 1969;56:486–488.
Taylor L Jr, Chitwood R, Dalman R, et al. Antiphospholipid antibodies in vascular surgery patients—A cross-sectional study. Ann Surg 1994;220:544–551.
Reyes H, Dearing L, Shoenfeld Y, et al. Antiphospholipid antibodies: A critique of their heterogeneity and hegemony. Semin Thromb Hemost 1994;20:89–100.
Hill RJ, Ens GE. Antiphospholipid antibody syndrome. Clin Hemost Rev 1990;4:1–4.
Conley C, Hartmann R. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952;31:621–622.
Bowie E, Thompson JJ, Pascuzzi CA, et al. Thrombosis in systemic lupus despite circulating anticoagulants. J Lab Clin Med 1963;62:416–430.
Khamashta M, Asherson R, Hughes G. Possible mechanisms of action of the antiphospholipid binding antibodies. Clin Exp Rheumatol 1989;7(Suppl)3:85–89.
Donaldson MC, Weinberg DS, Belkin M, et al. Screening for hypercoagulable states in vascular surgical practice: A preliminary study. J Vasc Surg 1990;11:825–831.
Nitecki S, Brenner B, Hoffman A, et al. Lower limb ischaemia in primary antiphospholipid syndrome. Eur J Vasc Surg 1993;7:414–419.
Shortell CK, Ouriel K, Green RM, et al. Vascular disease in the antiphospholipid syndrome: A comparison with the patient population with atherosclerosis. J Vasc Surg 1992;15:158–165.
Hughes GRV, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486–489.
Alarcon-Segovia D, Sanchez-Guerreo J. Primary antiphospholipid syndrome. J Rheumatol 1989;16:482–488.
Wilson J, Carrington E, Ledger W. Obstetrics and Gynecology, 7th ed. St. Louis: CV Mosby, 1983.
Sanchez-Guerrero J, Reyes E, Alarcon-Segovia D. Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol 1992;19:623–625.
Komori K, Okadome K, Onohara T, et al. High aortic occlusion associated with lupus anticoagulant. Eur J Vasc Surg 1992;6:302–306.
Triplett DA. Antiphospholipid antibodies and thrombosis, a consequence, coincidence or cause? Arch Pathol Lab Med 1993;117:78–88.
Brey R, Hart R, Sherman D, et al. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990;40:1190–1196.
Bick R, Ismail Y, Baker W Jr. Coagulation abnormalities in patients with precocious coronary artery thrombosis and patients failing coronary artery bypass grafting and percutaneous transcoronary angioplasty. Semin Thromb Hemost 1993;19:412–417.
Eldrup-Jorgensen J, Brace L, Flanigan DP, et al. Lupus-like anticoagulants and lower extremity arterial occlusive disease. Circulation (Suppl III) 1989;80:54–72.
DeFrang RD, Edwards JM, Moneta GL, et al. Repeat leg bypass after multiple prior bypass failures. J Vasc Surg 1994;19:268–276.
Ahn SS, Kalunian K, Rosove M, et al. Postoperative thrombotic complications in patients with the lupus anticoagulant: Increased risk after vascular procedures. J Vasc Surg 1988;7:749–756.
Khamashta M, Cuadrado M, Mujic F, et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;332:993–997.
Kluft C, Jie A, Rijken D, et al. Daytime fluctuations in blood of tissue-type plasminogen activator (tPA) and its fast-acting inhibitor (PAI-1). Thromb Haemost 1988;59:329–332.
Nunn DB. Symptomatic peripheral arteriosclerosis of patients under age 40. Am Surg 1973;39:224–228.
Yakes WF, Kumpe DA, Brown SB, et al. Percutaneous transluminal aortic angioplasty: Techniques and results. Radiology 1989;172:965–970.
Ravimandalam K, Rao VRK, Kumar S, et al. Obstruction of the infrarenal portion of the abdominal aorta: Results of treatment with balloon angioplasty. AJR 1991;156:1257–1260.
Long AL, Gaux JC, Raynaud AC, et al. Infrarenal aortic stents: Initial clinical experience and angiographic follow-up. Cardiovasc Intervent Radiol 1993;16:203–208.
Kumpe DA, Zwerdlinger S, Griffin DJ. Blue digit syndrome: Treatment with percutaneous transluminal angioplasty. Radiology 1988;166:37–44.
Brewer ML, Kinnison ML, Perler BA, et al. Blue toe syndrome: Treatment with anticoagulants and delayed percutaneous transluminal angioplasty. Radiology 1988;166:31–36.
Author information
Authors and Affiliations
About this article
Cite this article
Gagne, P.J., Vitti, M.J., Fink, L.M. et al. Young women with advanced aortoiliac occlusive disease: New insights. Annals of Vascular Surgery 10, 546–557 (1996). https://doi.org/10.1007/BF02000443
Issue Date:
DOI: https://doi.org/10.1007/BF02000443